Oregon Health and Science University, Department of Dermatology, Portland, OR, United States.
Front Immunol. 2019 Mar 12;10:414. doi: 10.3389/fimmu.2019.00414. eCollection 2019.
Sweet's syndrome, also known as Acute Febrile Neutrophilic Dermatosis, is a rare inflammatory condition. It is considered to be the prototype disease of neutrophilic dermatoses, and presents with acute onset dermal neutrophilic lesions, leukocytosis, and pyrexia. Several variants have been described both clinically and histopathologically. Classifications include . The cellular and molecular mechanisms involved in Sweet's syndrome have been difficult to elucidate due to the large variety of conditions leading to a common clinical presentation. The exact pathogenesis of Sweet's syndrome is unclear; however, new discoveries have shed light on the role of inflammatory signaling, disease induction, and relationship with malignancy. These findings include an improved understanding of inflammasome activation, malignant transformation into dermal infiltrating neutrophils, and genetic contributions. Continued investigations into effective treatments and targeted therapy will benefit patients and improve our molecular understanding of inflammatory diseases, including Sweet's syndrome.
Sweet 综合征,也称急性发热性嗜中性皮病,是一种罕见的炎症性疾病。它被认为是嗜中性皮肤病的典型疾病,表现为急性真皮嗜中性病变、白细胞增多和发热。临床上和组织病理学上都描述了几种变异型。分类包括... 由于导致共同临床表现的各种情况,Sweet 综合征的细胞和分子机制一直难以阐明。Sweet 综合征的确切发病机制尚不清楚;然而,新的发现揭示了炎症信号、疾病诱导和与恶性肿瘤的关系的作用。这些发现包括对炎症小体激活、恶性转化为真皮浸润性中性粒细胞以及遗传贡献的更好理解。对有效治疗和靶向治疗的持续研究将使患者受益,并提高我们对炎症性疾病(包括 Sweet 综合征)的分子认识。